|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.50 EUR | -1.09% |
|
+6.74% | +176.54% |
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 73Cr 84Cr 68Cr 63Cr 118.35Cr 8.05TCr 120.18Cr 804.6Cr 315.78Cr 4.01TCr 316.83Cr 309.87Cr 13TCr | P/E 2026 * |
37.8x | P/E 2027 * | 97.3x |
|---|---|---|---|---|---|
| Enterprise Value | 68Cr 78Cr 64Cr 58Cr 110.1Cr 7.49TCr 111.8Cr 748.52Cr 293.77Cr 3.73TCr 294.74Cr 288.27Cr 13TCr | EV / Sales 2026 * |
6.81x | EV / Sales 2027 * | 5.38x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.68% | ||
| 1 week | +6.74% | ||
| Current month | -0.68% | ||
| 1 month | +12.52% | ||
| 3 months | +78.00% | ||
| 6 months | +126.26% | ||
| Current year | +176.54% |
| 1 week | 12.94 |  | 15.48 |
| 1 month | 12.32 | | 15.48 |
| Current year | 5.05 | | 15.48 |
| 1 year | 3.05 | | 15.48 |
| 3 years | 2.62 | | 15.48 |
| 5 years | 2.62 | | 15.48 |
| 10 years | 2.62 | | 35.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/07/23 | Buy | Director | 5,300 | 0.0106% | ||
| 07/07/23 | Buy | Chief Executive Officer | 10,000 | 0.0201% | ||
| 07/07/23 | Buy | Founder | 10,000 | 0.0201% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.09% | +6.74% | +334.11% | +340.54% | 84Cr | |
| +0.57% | +1.18% | +0.07% | +15.51% | 4.85TCr | |
| -2.41% | -0.90% | +411.96% | +472.09% | 3.99TCr | |
| -1.16% | +12.96% | +28.81% | +7.27% | 3.87TCr | |
| -1.88% | -3.03% | +5.69% | +66.52% | 3.51TCr | |
| -1.74% | +5.12% | +14.44% | +44.64% | 2.98TCr | |
| -0.21% | -4.04% | +36.40% | +126.06% | 1.61TCr | |
| -2.85% | -3.92% | - | - | 1.61TCr | |
| -0.53% | +1.32% | +1.89% | +15.15% | 1.36TCr | |
| -1.19% | -1.32% | -1.73% | -34.97% | 1.26TCr | |
| Average | -1.21% | +1.85% | +92.40% | +116.98% | 2.51TCr | |
| Weighted average by Cap. | -1.21% | +2.06% | +80.98% | +108.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 12Cr 9.33Cr 8.56Cr 16Cr 1.1TCr 16Cr 109.93Cr 43Cr 547.77Cr 43Cr 42Cr 1.84TCr | 12Cr 14Cr 12Cr 11Cr 20Cr 1.36TCr 20Cr 136.1Cr 53Cr 678.16Cr 54Cr 52Cr 2.27TCr |
| Net income | 2.29Cr 2.63Cr 2.13Cr 1.96Cr 3.69Cr 251.23Cr 3.75Cr 25Cr 9.85Cr 125.07Cr 9.88Cr 9.67Cr 419.39Cr | 68L 78.22L 63.29L 58.11L 1.1Cr 75Cr 1.11Cr 7.46Cr 2.93Cr 37Cr 2.94Cr 2.87Cr 124.66Cr |
| Net Debt | -5.11Cr -5.88Cr -4.76Cr -4.37Cr -8.25Cr -561.33Cr -8.38Cr -56Cr -22Cr -279.46Cr -22Cr -22Cr -937.06Cr | -6.62Cr -7.61Cr -6.16Cr -5.65Cr -11Cr -726.67Cr -11Cr -73Cr -28Cr -361.77Cr -29Cr -28Cr -1.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | €14.50 | -1.09% | 1,97,578 |
| 31/26/31 | €14.66 | +4.71% | 10,52,589 |
| 30/26/30 | €14.00 | +3.09% | 4,72,097 |
| 29/26/29 | €13.58 | +2.88% | 2,21,321 |
| 28/26/28 | €13.20 | -3.23% | 3,09,495 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
